Showing results (31-40 of 209) with videos related to
Sort By:
Pageof 21
Expert Opinion on Investigational Drugs|November 18, 2008
Clevudine: a promising therapy for the treatment of chronic hepatitis BTarik Asselah, Olivier Lada, Rami Moucari, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
HCV direct-acting antiviral agents: the best interferon-free combinationsRaymond Schinazi, Philippe Halfon, Patrick Marcellin, et al.Antiviral Research|December 6, 2020
Perspectives on stopping nucleos(t)ide analogues therapy in patients with chronic hepatitis BIssam Tout, Pietro Lampertico, Thomas Berg, et al.The Lancet. Gastroenterology & Hepatology|October 15, 2019
Targets and future direct-acting antiviral approaches to achieve hepatitis B virus cureTarik Asselah, Dimitri Loureiro, Nathalie Boyer, et al.Antiviral Research|November 21, 2025
Bulevirtide for chronic hepatitis delta: from clinical trials to real life data: an expert opinion reportTarik Asselah, Homie Razavi, Hélène Fontaine, et al.Journal of Hepatology|June 5, 2012
Genomics and HCV infection: progression of fibrosis and treatment responseEmilie Estrabaud, Michel Vidaud, Patrick Marcellin, et al.Liver International : Official Journal of the International Association for the Study of the Liver|June 24, 2022
COVID-19-associated hepatic artery pseudoaneurysmsMichel Dupuis, Maxime Ronot, Tarik Asselah, et al.Current Opinion in Virology|September 11, 2023
Hepatitis-B virus: replication cycle, targets, and antiviral approachesNour Nasser, Pierre Tonnerre, Abdellah Mansouri, et al.Antiviral Research|November 17, 2022
Hepatitis D virus: Improving virological knowledge to develop new treatmentsPierre Khalfi, Patrick T Kennedy, Karim Majzoub, et al.Antiviral Chemistry & Chemotherapy|November 24, 2022
Active site polymerase inhibitor nucleotides (ASPINs): Potential agents for chronic HBV cure regimensRobert G Gish, Tarik Asselah, Katherine Squires, et al.Pageof 21